SELLAS Life Sciences Group (SLS) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.25
-0.2
-0.15
-0.1

Details

Expected EPS
-0.126667
Actual EPS
-0.1
Surprise EPS
0.03
Surprise Percent
+21.05%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.1 per share for Q4 2024.

0 Comments

Share your thoughts